EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance

Sydney Kusumoputro iD, Christian Au, Katie H Lam, Nathaniel Park iD, Austin Hyun, Emily Kusumoputro iD, Xiang Wang iD, Tian Xia iD

Nanomaterials · 26.12.2023 · 14 (1) · 67

DOI: 10.3390/nano14010067 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 26.12.2023. Verfasst von Sydney Kusumoputro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Drexel University College of Medicine, Philadelphia, PA 19129, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: California NanoSystems Institute, University of California Los Angeles.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver-targeting nanoparticles have emerged as a promising platform for the induction of immune tolerance by taking advantage of the liver’s unique tolerogenic properties and nanoparticles’ physicochemical flexibility. Such an approach provides a versatile solution to the treatment of a diversity of immunologic diseases. In this review, we begin by assessing the design parameters integral to cell-specific targeting and the tolerogenic induction of nanoplatforms engineered to target the four critical immunogenic hepatic cells, including liver sinusoidal epithelial cells (LSECs), Kupffer cells (KCs), hepatic stellate cells (HSCs), and hepatocytes. We also include an overview of multiple therapeutic strategies in which nanoparticles are being studied to treat many allergies and autoimmune disorders. Finally, we explore the challenges of using nanoparticles in this field while highlighting future avenues to expand the therapeutic utility of liver-targeting nanoparticles in autoimmune processes.

Schlagwörter

Stichwörter der Autor:innen

allergiesautoimmune diseasesimmune toleranceliver-targeting nanoparticles

Autor:innen und Institutionen

  • Department of Medicine, Drexel University College of Medicine, Philadelphia, PA 19129, USA.
  • Department of Ecology and Evolutionary Biology, University of California, Los Angeles, CA 90095, USA.
  • Department of Bioengineering, University of California, Los Angeles, CA 90095, USA.
  • Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90007, USA.
  • Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA 90095, USA.
  • Department of Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA.

ORCID-Profile: Sydney Kusumoputro, Nathaniel Park, Emily Kusumoputro, Xiang Wang, Tian Xia

Förderung

  • California NanoSystems Institute, University of California Los Angeles

Zitieren

APA

Kusumoputro, S., Au, C., Lam, K. H., Park, N., Hyun, A., Kusumoputro, E., Wang, X., & Xia, T. (2023). Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance. Nanomaterials, 14(1), 67. https://doi.org/10.3390/nano14010067

Vancouver

Kusumoputro S, Au C, Lam KH, Park N, Hyun A, Kusumoputro E, et al. Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance. Nanomaterials. 2023;14(1):67. doi:10.3390/nano14010067

BibTeX
@article{Kusumoputro2023,
  author = {Kusumoputro, Sydney and Au, Christian and Lam, Katie H and Park, Nathaniel and Hyun, Austin and Kusumoputro, Emily and Wang, Xiang and Xia, Tian},
  title = {Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance},
  journal = {Nanomaterials},
  year = {2023},
  volume = {14},
  number = {1},
  pages = {67},
  doi = {10.3390/nano14010067}
}
Kostenlos starten →